Dr. Luca Szalontay, Assistant Professor of Pediatrics at Columbia University Medical Center, discusses the work of Columbia's Initiative for Drug Delivery Innovation which is exploring new treatments for pediatric brain tumors utilizing Convection Enhanced Delivery and Focused Ultrasound. This initiative has launched a new clinical trial using Focused Ultra ... Show More
Jun 2023
TWiPO #111: A Discussion on Oncofertility/Fertility Preservation with Dr. Seth Rotz
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/ACFprGG10M0 In this episode, our host, Dr. Timothy Cripe from Nationwide Children’s Hospital, is joined by Dr. Seth Rotz - pediatric hematologist/oncologist and the Director of the Fertility Preservation Program at the Cleveland Clin ... Show More
26m 55s
Apr 2023
TWiPO #110: Discussing the ”Gift from a Child” Program with Al Gustafson & Dr. Angela Waanders
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/jj3wJU0G7GI Listen in as our hosts, Dr. Tim Cripe & Dr. Brenda Weigel, are joined by Al Gustafson, from The Swifty Foundation, and Dr. Angela Waanders, from Lurie Children's Hospital of Chicago, to discuss the "Gift from a Child" pro ... Show More
33m 48s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and the ... Show More
24m 31s
Apr 2024
PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D.
In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, ... Show More
36m 1s
Feb 2025
Can I trust the FDA? (from thalidomide to cough medicine)
#206
Melissa and Jam address a listener's question about the FDA's reliability in approving products. They discuss the intersection of chemistry, government, and society, focusing on FDA's role in regulating food and drugs. The episode includes a deep dive into the historical tha ... Show More
30m 23s
Oct 2023
The FDA: A Spoonful of Safety Makes The Medicine Go Down
On this week's episode of the pod, we are talking about a drug that's been available for decades but is suddenly being pulled from shelves: phenylephrine (something you've probably reached for when you've been congested). We bring on an expert, Dr. Mikkael Sekeres, a Professor of ... Show More
52m 15s
Feb 2025
Type 2 Diabetes Treatments and Major Adverse Cardiovascular Events by Age and Sex, Simvastatin with Rifaximin for Decompensated Liver Cirrhosis, Approved vs Off-label Doxepin Formulation Trends and mo
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from February 1-7, 2025.
9m 51s
Sep 2024
Updates in Canine Melanoma with Dr. Fan
Melanoma is a commonly encountered, often metastatic, disease in canine patients. In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites Dr. Timothy Fan to share advice on the clinical management of melanoma in practice. Dr. Fans offers insights on staging, surgic ... Show More
35m 51s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal improvem ... Show More
24m 4s